Article Text

PDF
P154 Safety of tiotropium in pre-school children with symptomatic persistent asthma

Abstract

H Bisgaard has been a consultant for AstraZeneca, Boehringer Ingelheim and Chiesi;

M Vandewalker has received research grants and personal fees from Boehringer Ingelheim;

L Graham made no relevant disclosures;

P Moroni-Zentgraf is an employee of Boehringer Ingelheim;

M Engel is an employee of Boehringer Ingelheim;

G El Azzi is an employee of Boehringer Ingelheim;

SD Vulcu is an employee of Boehringer Ingelheim;

H Finnigan is an employee of Boehringer Ingelheim;

EJLE Vrijlandt has received personal fees from Boehringer Ingelheim

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.